Chiral Bis(Oxazolinyl)thiophenes for Enantioselective Cu(II)
945
7.16–7.35 (m, 7H), 7.53 (d, J = 1.6 Hz, 1H), 8.13 (s, 1H);
13C NMR (100 MHz, CDCl3): d = 41.3, 79.4, 112.9,
113.5, 114.2, 121.6, 122.8, 125.7, 127.7, 127.8, 128.0,
129.2, 135.2, 138.8; ESI-MS: m/z (%) = 301 ([M?H]?,
100).
J2 = 12.6 Hz, 1H), 5.01 (dd, J1 = 7.5 Hz, J2 = 12.6 Hz,
1H), 5.13 (d, J = 8.0 Hz, 1H), 7.01 (dd, J1 = 0.6 Hz,
J2 = 2.5 Hz, 1H), 7.07 (m, 1H), 7.16–7.28 (m, 3H), 7.34
(d, J = 8.2 Hz, 1H), 7.38 (m, 1H), 7.41 (dd, J1 = 0.7 Hz,
J2 = 8.0 Hz, 1H), 7.44 (t, J = 1.8 Hz, 1H), 8.07 (s, 1H);
13C NMR (100 MHz, CDCl3): d = 41.2, 79.3, 111.7,
113.9, 118.9, 120.4, 121.7, 123.1, 123.3, 126.1, 126.6,
130.6, 131.0, 131.3, 136.7, 141.7; ESI-MS: m/z (%) = 346
([M?H]?, 100).
2.2.6 (S)-3-[1-(2-Methoxyphenyl)-2-Nitroethyl]-1H-Indole
(4f)
Yield: 96 %; colorless solid; mp 92–95 °C; HPLC analysis
[Daicel Chiralcel OD-H, 30 % i-PrOH/hexane, 1.0 ml/min;
2.2.9 (S)-3-[1-(3-Nitrophenyl)-2-Nitroethyl]-1H-Indole
t
minor 13.4 min, tmajor 15.3 min, k = 254 nm (UV)] gave the
(4i)
isomeric composition of the product: 88 % ee; [a]D20
=
-57.0 (c 1.0, CH2Cl2) [Lit [34]. [a]2D0 = ?49.6 (c 0.75,
CH2Cl2), 61 % ee, (R) configuration]; 1H NMR (400 MHz,
CD3COCD3): d = 3.94 (s, 3H), 5.19 (dd, J1 = 1.5 Hz,
J2 = 8.0 Hz, 2H), 5.64 (t, J = 8.0 Hz, 1H), 6.85 (t,
J = 7.5 Hz, 1H), 6.95–7.06 (m, 2H), 7.08–7.16 (m, 1H),
7.18–7.29 (m, 2H), 7.36–7.45 (m, 2H), 7.53 (d, J = 8.0 Hz,
1H), 10.27 (s, 1H); 13C NMR (100 MHz, CD3COCD3):
d = 35.9, 56.1, 78.9, 111.9, 112.4, 114.4, 119.5, 119.9,
121.4, 122.6, 123.5, 127.7, 129.0, 129.3, 129.6, 137.8, 158.0;
ESI-MS: m/z (%) = 297 ([M?H]?, 100).
Yield: 97 %; yellow oil; HPLC analysis [Daicel Chiralcel
OD-H, 30 % i-PrOH/hexane, 1.0 ml/min; tmajor 34.5 min,
tminor 48.4 min, k = 254 nm (UV)] gave the isomeric
composition of the product: 92 % ee; [a]2D0 = ?12.7 (c 1.0,
CH2Cl2) [Lit [12]. [a]2D0 = -17.9 (c 0.48, CH2Cl2), 95 %
ee, (R) configuration]; 1H NMR (300 MHz, CDCl3):
d = 5.02 (dd, J1 = 9.0 Hz, J2 = 12.6 Hz, 1H), 5.12 (dd,
J1 = 6.9 Hz, 1H), 5.33 (t, J = 7.8 Hz, 1H), 7.10–7.13 (m,
2H), 7.24 (t, J = 8.4 Hz, 1H), 7.40 (d, J = 8.4 Hz, 2H),
7.53 (t, J = 7.8 Hz, 1H), 7.72 (d, J = 7.5 Hz, 1H), 8.16 (d,
J = 8.1 Hz, 1H), 8.23 (s, 1H), 8.25 (s, 1H); 13C NMR (100
MHz, CDCl3): d = 41.1, 78.7, 111.7, 112.8, 118.5, 120.1,
121.5, 122.5, 122.7, 123.1, 125.5, 129.8, 134.0, 136.5,
141.6, 148.6; ESI-MS: m/z (%) = 312 ([M?H]?, 100).
2.2.7 (S)-3-[1-(2-Chlorophenyl)-2-Nitroethyl]-1H-Indole
(4g)
Yield: 87 %; colorless oil; HPLC analysis [Daicel Chiral-
cel OD-H, 30 % i-PrOH/hexane, 1.0 ml/min; tminor
16.5 min, tmajor 25.8 min, k = 254 nm (UV)] gave the
isomeric composition of the product: 73 % ee;
[a]D20 = ?80.2 (c 1.0, CH2Cl2) [Lit [34]. [a]2D0 = ?79.4
2.2.10 (S)-3-[1-(4-Methoxyphenyl)-2-Nitroethyl]-1H-
Indole (4j)
Yield: 90 %; colorless solid; mp 142–144 °C; HPLC ana-
lysis [Daicel Chiralcel OD-H, 30 % i-PrOH/hexane,
1.0 ml/min; tmajor 19.1 min, tminor 24.7 min, k = 254 nm
(UV)] gave the isomeric composition of the product: 91 %
ee; [a]2D0 = ?30.5 (c 1.0, CH2Cl2) [Lit [17]. [a]2D0 = -11.8
1
(c 0.95, CH2Cl2), 72 % ee]; H NMR (400 MHz, CD3-
COCD3): d = 5.23 (dd, J1 = 7.8 Hz, J2 = 13.2 Hz, 1H),
5.32 (dd, J1 = 8.3 Hz, J2 = 13.2 Hz, 1H), 5.76 (t,
J = 8.0 Hz, 1H), 6.98–7.06 (m, 1H), 7.08–7.15 (m, 1H),
7.21–7.31 (m, 2H), 7.43 (m, 2H), 7.44–7.50 (m, 1H),
7.51–7.54 (m, 1H), 7.56 (d, J = 7.9 Hz, 1H), 10.33 (s, 1H);
13C NMR (100 MHz, CDCl3): d = 38.1, 77.8, 111.5,
113.3, 119.0, 120.1, 120.1, 122.1, 122.9, 126.3, 127.4,
129.0, 129.1, 130.2, 133.9, 136.6; ESI-MS: m/z (%) = 301
([M?H]?, 100).
1
(c 0.11, CH2Cl2), 44 % ee, (R) configuration]; H NMR
(500 MHz, CDCl3): d = 3.78 (s, 3H), 4.89 (dd,
J1 = 8.4 Hz, J2 = 12.3 Hz, 1H), 5.03 (dd, J1 = 7.5 Hz,
J2 = 12.3 Hz, 1H), 5.14 (t, J = 8.0 Hz, 1H), 6.81–6.87
(m, 2H), 7.00 (dd, J1 = 0.7 Hz, J2 = 2.5 Hz, 1H), 7.06 (t,
J = 7.5 Hz, 1H), 7.18 (t, J = 7.5 Hz, 1H), 7.21–7.25 (m,
2H), 7.35 (d, J = 8.1 Hz, 1H), 7.44 (dd, J1 = 0.7 Hz,
J2 = 8.0 Hz, 1H), 8.06 (s, 1H); 13C NMR (100 MHz,
CDCl3): d = 41.1, 55.4, 80.0, 111.5, 114.5, 115.0, 119.2,
120.2, 121.6, 122.9, 126.3, 129.0, 131.4, 136.8, 159.2; ESI-
MS: m/z (%) = 297 ([M?H]?, 100).
2.2.8 (S)-3-[1-(3-Bromophenyl)-2-Nitroethyl]-1H-Indole
(4h)
Yield: 95 %; colorless oil; HPLC analysis [Daicel Chiral-
cel OD-H, 30 % i-PrOH/hexane, 1.0 ml/min; tmajor
21.7 min, tminor 30.8 min, k = 254 nm (UV)] gave the
isomeric composition of the product: 94 % ee;
[a]D20 = ?13.5 (c 1.0, CH2Cl2) [Lit [12]. [a]2D0 = -15.8
2.2.11 (S)-3-[1-(4-Chlorophenyl)-2-Nitroethyl]-1H-Indole
(4k)
1
(c 0.64, CH2Cl2), 97 % ee, (R) configuration]; H NMR
Yield: 94 %; colorless solid; mp 133–134 °C; HPLC ana-
lysis (Daicel Chiralcel OD-H, 30 % i-PrOH/hexane,
(500 MHz, CDCl3): d = 4.88 (dd, J1 = 8.4 Hz,
123